Fig. 1From: Pharmacological strategies to reduce exacerbation risk in COPD: a narrative reviewTherapeutic recommendations based on exacerbation phenotype. ICS, inhaled corticosteroid; LABA, long-acting β2-agonist; LAMA, long-acting muscarinic antagonistBack to article page